Increased collagen propeptides in the skin of a scleredema patient but no change in re-epithelialisation rate

Acta Dermato-Venereologica

Volumn 76, Issue 4, 1996, Pages 305-309

  Haapasaari, K M ^a   Kallioinen, M ^a   Tasanen, K ^a   Risteli, J ^a   Palatsi, R ^a   Oikarinen, A ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; GLYCOSAMINOGLYCAN; STEROID;

ADULT; ARTICLE; CASE REPORT; EPITHELIZATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SCLEREDEMA;

ABDOMEN; ANTI-INFLAMMATORY AGENTS; CASE-CONTROL STUDIES; COLLAGEN; CONNECTIVE TISSUE; DISEASE PROGRESSION; EPITHELIUM; FIBROSIS; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; GLYCOSAMINOGLYCANS; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PREDNISOLONE; PROCOLLAGEN; PROTEIN PRECURSORS; SCLEREDEMA ADULTORUM; SKIN; TIME FACTORS; UP-REGULATION;

EID: 0030036790     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Fleischmajer R, Faludi G, Krol S. Scleredema and diabetes mellitus. Arch Dermatol 1970; 101: 21-37.
2. Fleischmajer R, Perlish J. Glycosaminoglycosis in scleroderma and scleredema. J Invest Dermatol 1972; 58: 129-132.
3. Venencie PY, Powell FC, Su WPD, Percy HO. Scleredema: a review of thirty-three cases. J Am Acad Dermatol 1988; 11: 128-134.
4. Ohta A, Uitto J, Oikarinen AI, Palatsi R, Mitrane M, Bancila EA, et al. Paraproteinemia in patients with scleredema. J Am Acad Dermatol 1987; 16: 90-107.
5. Oikarinen A, Ala-Kokko L, Palatsi R, Peltonen L, Uitto J. Scleredema and paraproteinemia. Enhanced collagen production and elevated type I procollagen messenger RNA level in fibroblasts grown from cultures from the fibrotic skin of a patient. Arch Dermatol 1987; 123: 220-229.
6. Varga J, Gotta S, Li L, Sollberg S, Di Leonardo M. Scleredema adultorum: case report and demonstration of abnormal expression of extracellular matrix genes in skin fibroblasts in vivo and in vitro. Br J Dermatol 1995; 132: 992-999.
7. Kiistala U. Suction blister device for separating viable epidermis from dermis. J Invest Dermatol 1968; 50: 129-137.
8. Oikarinen A, Autio P, Kiistala D, Risteli L, Risteli J. A new method to measure type I and III collagen synthesis in human skin in vivo. Demonstration of decreased collagen synthesis after topical glucocorticoid treatment. J Invest Dermatol 1992; 98: 220-225.
9. Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat AP, Risteli L. Rapid equilibrium radioimmunoassay for the aminoterminal propeptide of human type III procollagen. Clin Chem 1988; 34: 715-718.
10. Risteli L, Risteli J. Biochemical markers of bone metabolism. Ann Med 1993; 25: 385-393.
11. Melkko J, Niemi S, Risteli L, Risteli J. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 1990; 7: 1328-1332.
12. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993; 39: 635-640.
13. Van Neste D. Healing kinetics of epidermal wounds are not influenced by acute irritation induced by sodium laurylsulphate. J Invest Dermatol 1990; 94: 403.
14. Lyonnet S, Frappaz A, Van Neste D, Nicolas JF, Thivolet J. Effect of basic fibroblast growth factor on epidermal wound healing. J Invest Dermatol 1991; 96: 1022.
15. Autio P, Oikarinen A, Melkko J, Risteli J, Risteli L. Systemic glucocorticoids decrease the synthesis of type I and type III collagen in human skin in vivo, whereas isotretinoin has little effect. Br J Dermatol 1994; 131: 660-663.
16. Heickendorff L, Zachariae H, Bjerring P, Halkier-Sørensen L, Søndergaard K. The use of serologic markers for collagen synthesis and degradation in systemic sclerosis. J Am Acad Dermatol 1995; 32: 584-588.
17. Heickendorff L, Parvez A, Bjerring P, Halkier-Sørensen L, Zachariae H. Serum aminoterminal propeptide of type III procollagen in systemic sclerosis. A follow-up. Investigations in subclasses and during therapy. Acta Derm Venereol (Stockh) 1991; 71: 185-188.